Which patients at risk of cardiovascular disease might benefit the most from inclisiran? Polish experts' opinion. The compromise between EBM and possibilities in healthcare

被引：17

作者：

Banach, Maciej ^{[1
,2
,3
]}

Kazmierczak, Jaroslaw ^{[4
]}

Mitkowski, Przemyslaw ^{[5
]}

Wita, Krystian ^{[6
]}

Broncel, Marlena ^{[7
]}

Gasior, Mariusz ^{[8
]}

Gierlotka, Marek ^{[9
]}

Gil, Robert ^{[10
]}

Jankowski, Piotr ^{[11
,12
]}

Niewada, Maciej ^{[13
,14
]}

Witkowski, Adam ^{[15
]}

机构：

[1] Med Univ Lodz MUL, Dept Prevent Cardiol & Lipidol, 281-289 Rzgowska St, PL-93338 Lodz, Poland

[2] Polish Mothers Mem Hosp Res Inst PMMHRI, Dept Cardiol & Congenital Dis Adults, Lodz, Poland

[3] Univ Zielona Gora, Cardiovasc Res Ctr, Zielona Gora, Poland

[4] Pomeranian Med Univ, Dept Cardiol, Szczecin, Poland

[5] Poznan Univ Med Sci, Dept Cardiol 1, Poznan, Poland

[6] Med Univ Silesia, Sch Med Katowice, Dept Cardiol 1, Katowice, Poland

[7] Med Univ Lodz MUL, Dept Internal Dis & Clin Pharmacol, Lodz, Poland

[8] Med Univ Silesia, Fac Med Sci Zabrze, Dept Cardiol 3, Katowice, Poland

[9] Univ Opole, Inst Med Sci, Dept Cardiol, Univ Hosp, Opole, Poland

[10] Minist Interior & Adm, Cent Clin Hosp, Dept Invas Cardiol, Warsaw, Poland

[11] Ctr Postgrad Med Educ, Dept Internal Med & Geriatr Cardiol, Warsaw, Poland

[12] Ctr Postgrad Med Educ, Sch Publ Hlth, Dept Epidemiol & Hlth Promot, Warsaw, Poland

[13] Med Univ Warsaw, Dept Expt & Clin Pharmacol, Warsaw, Poland

[14] HealthQuest, Warsaw, Poland

[15] Inst Cardiol, Dept Intervent Cardiol & Angiol, Warsaw, Poland

来源：

ARCHIVES OF MEDICAL SCIENCE | 2022年 / 18卷 / 03期

关键词：

REGISTRY;

D O I：

10.5114/aoms/147435

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：569 / 576

页数：8

共 35 条

[1] PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021 [J].

Banach, Maciej ;

Burchardt, Pawl ;

Chlebus, Krzysztof ;

Dobrowolski, Piotr ;

Dudek, Dariusz ;

Dyrbus, Krzysztof ;

Gasior, Mariusz ;

Jankowski, Piotr ;

Jozwiak, Jacek ;

Klosiewicz-Latoszek, Longina ;

Kowalska, Irina ;

Malecki, Maciej ;

Prejbisz, Aleksander ;

Rakowski, Michat ;

Rysz, Jacek ;

Solnica, Bogdan ;

Sitkiewicz, Dariusz ;

Sygitowicz, Grazyna ;

Sypniewska, Grazyna ;

Tomasik, Tomasz ;

Windak, Adam ;

Zozulinska-Ziolkiewicz, Dorota ;

Cybulska, Barbara .

ARCHIVES OF MEDICAL SCIENCE, 2021, 17 (06) :1447-1547

[2] Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP) [J].

Banach, Maciej ;

Penson, Peter E. ;

Vrablik, Michal ;

Bunc, Matjaz ;

Dyrbus, Krzysztof ;

Fedacko, Jan ;

Gaita, Dan ;

Gierlotka, Marek ;

Jarai, Zoltan ;

Magda, Stefania Lucia ;

Margetic, Eduard ;

Margoczy, Roman ;

Durak-Nalbantic, Azra ;

Ostadal, Petr ;

Pella, Daniel ;

Trbusic, Matias ;

Udroiu, Cristian Alexandru ;

Vlachopoulos, Charalambos ;

Vulic, Dusko ;

Fras, Zlatko ;

Dudek, Dariusz ;

Reiner, Zeljko .

PHARMACOLOGICAL RESEARCH, 2021, 166

[3] What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcome trials: ODYSSEY and FOURIER? [J].

Banach, Maciej ;

Penson, Peter E. .

CARDIOVASCULAR RESEARCH, 2019, 115 (03) :E26-E31

[4]

basiw.mz.gov, MAPS HLTH NEEDS MINI

[5]

clinicaltrials, disease: trial design and rationale for the DECISION QFR randomized trial

[6] Estimation of the major cardiovascular events prevention with Inclisiran [J].

Cordero, Alberto ;

Santos-Gallego, Carlos G. ;

Facila, Lorenzo ;

Rodriguez-Manero, Moises ;

Bertomeu-Gonzalez, Vicente ;

Castellano, Jose M. ;

Seijas-Amigo, Jose ;

Nunez, Julio ;

Zuazola, Pilar ;

Gonzalez-Juanatey, Jose R. ;

Badimon, Juan J. .

ATHEROSCLEROSIS, 2020, 313 :76-80

[7] Extreme cardiovascular risk-do we need a new risk category? [J].

Dyrbus, Krzysztof ;

Gasior, Mariusz ;

Penson, Peter E. ;

Banach, Maciej .

EUROPEAN HEART JOURNAL, 2022, 43 (19) :1784-1786

[8] Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) registry [J].

Dyrbus, Krzysztof ;

Gasior, Mariusz ;

Desperak, Piotr ;

Trzeciak, Przemyslaw ;

Nowak, Jolanta ;

Penson, Peter E. ;

Osadnik, Tadeusz ;

Banach, Maciej .

ATHEROSCLEROSIS, 2021, 333 :16-23

[9] Inclisiran-New hope in the management of lipid disorders? [J].

Dyrbus, Krzysztof ;

Gasior, Mariusz ;

Penson, Peter ;

Ray, Kausik K. ;

Banach, Maciej .

JOURNAL OF CLINICAL LIPIDOLOGY, 2020, 14 (01) :16-27

[10] The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: Results from the TERCET registry with 19,781 individuals [J].

Dyrbus, Krzysztof ;

Gasior, Mariusz ;

Desperak, Piotr ;

Osadnik, Tadeusz ;

Nowak, Jolanta ;

Banach, Maciej .

ATHEROSCLEROSIS, 2019, 288 :33-41

← 1 2 3 4 →